ARCHIVES

Letter: The Lesson From Dana-Farber

This article is from The Cancer Letter archive.

Vol. 21 No. 30 | July 28, 1995

Download PDF Visit The Full Archive

Related Articles

Research Dollars Save Money, Lives, Scientists Tell Senate

May 3, 1991

Changes In Labels Of Anticancer Drugs Suggested; Response Is Slow

October 8, 1976

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

June 28, 2013

Science Policcy: HHS Concludes NIH May und Human Stem Cell REsearch

January 22, 1999

FDA Delays Decision On Avastin Approval For Breast Cancer

September 24, 2010

GAO Says Multiple Year Funding Not Legal; Weicker Demands Assurance That Administration Will Comply

March 29, 1985